跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AXCEL CINNARIZINE TABLETS 25 mg - HSA Drug Approval Details
Approvals
/
HSA
/
AXCEL CINNARIZINE TABLETS 25 mg
Approved
THERAPEUTIC
AXCEL CINNARIZINE TABLETS 25 mg
KOTRA PHARMA (M) SDN BHD
🇸🇬 Health Sciences Authority
Approval Date
May 17, 1999
Approval ID
1d9d3acd6c7b08d2
Company
KOTRA PHARMA (M) SDN BHD
Type
Therapeutic
Approval Details
Approval Id
1d9d3acd6c7b08d2
Drug Name
AXCEL CINNARIZINE TABLETS 25 mg
Product Name
AXCEL CINNARIZINE TABLETS 25 mg
Approval Number
SIN10935P
Approval Date
1999-05-17
Registrant
KOTRA PHARMA MARKETING
Licence Holder
KOTRA PHARMA MARKETING
Drug Type
Therapeutic
Forensic Classification
Pharmacy Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
N07CA02
Atc Item Name
cinnarizine
Pharma Manufacturer Name
KOTRA PHARMA MARKETING
Company Detail Path
/organization/kotra-pharma-marketing
Active Ingredients
CINNARIZINE
25 mg
CINNARIZINE
25 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 17, 1999
Approval ID
1d9d3acd6c7b08d2
Type
Therapeutic
Back to HSA Approvals